Drug
Florbetaben
Florbetaben: highest development phase Phase 3, developed by Lantheus Biosciences Ltd.. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Lantheus Biosciences Ltd.
Trials
| Drug | Phase | Indication |
|---|---|---|
| Florbetaben (BAY94-9172) NCT01020838 | Phase 3 | Alzheimer Disease |
| Florbetaben (BAY94-9172) NCT00750282 | Phase 2 | Alzheimer Disease |
Latest
No recent events.
Follow Florbetaben on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.